UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033878
Receipt number R000038188
Scientific Title Treatment Utilizing Virtual Reality for Social Anxiety Disorder: A Feasibility Study
Date of disclosure of the study information 2018/08/24
Last modified on 2023/05/28 07:55:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Treatment Utilizing Virtual Reality for Social Anxiety Disorder: A Feasibility Study

Acronym

Treatment Utilizing Virtual Reality for Social Anxiety Disorder: A Feasibility Study

Scientific Title

Treatment Utilizing Virtual Reality for Social Anxiety Disorder: A Feasibility Study

Scientific Title:Acronym

Treatment Utilizing Virtual Reality for Social Anxiety Disorder: A Feasibility Study

Region

Japan


Condition

Condition

social anxiety disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We aim to investigate whether the interview in which facial expressions are changed by using the virtual reality technology can be effectively and safely performed for patients with social anxiety disorder

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

safety of the system

Key secondary outcomes

LSAS-J score decrease at 8 weeks
LSAS-J score decrease at the end of the intervention (16 weeks)
LSAS-J score decrease at 24 weeks
FNE score decrease at 8 weeks
FNE score decrease at the end of the intervention (16 weeks)
CSQ-8 score at 8 weeks
CSQ-8 score at the end of the intervention (16 weeks)
WAI-SF score at the end of first sessions
WAI-SF score at the end of eighth sessions
WAI-SF score at the end of sixteenth sessions
dropout rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

40 minutes interview via WEB conference system (once a week over 16 weeks) in which the clinician's facial expression will be altered (smily or sadly) utilizing virtual reality technology

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with SAD (DSM-5) who are not decisionally impaired

Key exclusion criteria

History of organic mental disorders
Coexistence of substance use disorders within 12 months
History of bipolar disorder or psychotic disorder
Received other structured psychotherapy within 12 months
Coexistence of serious or unstable physical illness
Patients with moderate to severe suicidality
Judged inappropriate for the purpose of this research for other reasons by the Research Director

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Gen
Middle name
Last name Shiihashi

Organization

Shonan Keiiku hospital

Division name

Doctors

Zip code

252-0816

Address

4360 Endo, Hujisawa city, Kanagawa, Japan

TEL

0466-48-0050

Email

g-shiihashi@keiiku.gr.jp


Public contact

Name of contact person

1st name Toshiro
Middle name
Last name Horigome

Organization

Shonan Keiiku hospital

Division name

Doctors

Zip code

252-0816

Address

4360 Endo, Hujisawa city, Kanagawa, Japan

TEL

0466-48-0050

Homepage URL


Email

toshirou.ho@gmail.com


Sponsor or person

Institute

Shonan Keiiku hospital

Institute

Department

Personal name



Funding Source

Organization

Novartis Pharma K.K., Otsuka Pharmaceutical, Mochida Pharmaceutical, Shionogi, Takeda Pharmaceutical, etc

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shonan Keiiku hospital

Address

4360 Endo, Hujisawa city, Kanagawa, Japan

Tel

0466-48-0050

Email

k-miyazaki@keiiku.gr.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

湘南慶育病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2018 Year 08 Month 24 Day


Related information

URL releasing protocol

https://doi.org/10.3389/fpsyg.2023.1030050

Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.3389/fpsyg.2023.1030050

Number of participants that the trial has enrolled

4

Results

Results suggest that this system is safe to use and may be effective in treating social anxiety disorder.

Results date posted

2023 Year 05 Month 28 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

1 male, 3 females, mean age; 31.0 years

Participant flow

Recruitment of the participants was conducted through referrals from their primary psychiatrists.

Adverse events

none

Outcome measures

WAI-SF, CSQ-8, LSAS-J, FNE

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 06 Day

Date of IRB

2018 Year 08 Month 06 Day

Anticipated trial start date

2018 Year 08 Month 25 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 08 Month 23 Day

Last modified on

2023 Year 05 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038188


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name